Tag: Sanofi
-
Update of agreement between AstraZeneca, Swedish … – AstraZeneca
11 April 2023 07:00 BST AstraZeneca, Swedish Orphan Biovitrum AB (publ) (Sobi) and Sanofi have updated and simplified their contractual arrangements regarding the development and commercialization of nirsevimab in the US. In view of the upcoming launch of nirsevimab in the US and other markets, the simplification of the previous arrangements clarifies the roles and…
-
California sued Novo Nordisk for “driving up the price” of insulin
Novo Nordisk is one of three pharmaceutical companies being sued by the US state of California for overcharging for insulin. More than 10 percent of the state’s adult population is diabetic, equivalent to at least 3 million people, and California Attorney General Rob Bonta claims many can’t afford drugs that “could mean the difference between…
-
California sued Novo Nordisk for “driving up the price” of insulin
Novo Nordisk is one of three pharmaceutical companies being sued by the US state of California for overcharging for insulin. More than 10 percent of the state’s adult population is diabetic, equivalent to at least 3 million people, and California Attorney General Rob Bonta claims many can’t afford drugs that “could mean the difference between…
-
Foreign companies are stepping up research and development
Foreign companies are an essential factor in achieving Finland’s goals, as they accounted for almost a third of companies’ RDI investments in 2020. The Finnish government has set a national target of raising RDI investment to 4% of GDP, but this cannot be achieved without a significant increase in investment by companies and the public…
-
FACTS: Three vaccines are left after the drop of AstraZeneca
Get an overview here of the four approved vaccines – and the other three that Denmark has put a ticket on, if they are approved for use. * Pfizer / BioNTech: Was approved by the EU Commission on 21 December, and the first Danes were vaccinated on 27 December. Denmark has secured doses to vaccinate…
-
Marketing authorization of Covid-19 vaccines in Iceland
The Janssen vaccine (of which Johnson & Johnson is parent company) has obtained a conditional marketing authorization in Iceland. The European Medicines Agency recommended its conditional marketing authorization, which was confirmed by the European Commission. It is the fourth COVID-19 vaccine approved in Iceland and the rest of Europe. It differs from others in that…
-
FACTS: Denmark has put in a ticket for 25 million vaccines
This is due to the fact that several serious cases of blood clots have been reported among vaccinated people in Europe – including one death in Denmark. The Danish Medicines Agency and the European Medicines Agency (EMA) are now investigating whether there may be a connection between the blood clots and the vaccine. In total,…
-
Novo Nordisk is convicted of violating a competitor
The two companies are direct competitors in the diabetes treatment market. But in 2019, Novo Nordisk issued a press release comparing Novo Nordisk’s drug Tresiba with Sanofi’s Toujeo, which was misleading, the court states. The judges emphasize that Novo Nordisk also crossed the line in 2017 by issuing an illegal press release, and that Sanofi…
-
Denmark joins EU agreement on coronavirus vaccine
Denmark has decided to accede to a preliminary agreement on the purchase of a vaccine against coronavirus, which the EU has entered into with Pfizer and BioNTech. It writes Health Minister Magnus Heunicke (S) on Twitter. The EU signed the agreement with Phizer and BioNTech on 11 November. The agreement includes the purchase of 200…
-
Sweden has bought more vaccines against influenza
Sweden has in high competition bought more vaccines against the coming seasonal flu. 180,000 extra doses will be distributed between the country’s regions. The corona pandemic is expected to increase interest in getting vaccinated against seasonal flu as well, and many countries have therefore placed extra orders with manufacturers. So does Sweden. The new agreement…
-
Denmark secures millions of doses of possible coronavina vaccine
The European Commission has, on behalf of all EU countries, entered into another agreement with a vaccine manufacturer – this time Sanofi-GSK – to supply 300 million vaccine doses against covid-19. However, the agreement only applies if the vaccine proves to be safe and effective and if the drug authorities approve it. It writes the…
